Paroxetine-mediated GRK2 Inhibition Improves Cardiovascular Outcomes Post Myocardial Infarction
Publication
, Conference
Schumacher-Bass, SM; Gao, E; Chuprun, K; Tesmer, JJ; Koch, WJ
Published in: CIRCULATION RESEARCH
2013
Duke Scholars
Published In
CIRCULATION RESEARCH
EISSN
1524-4571
ISSN
0009-7330
Publication Date
2013
Volume
113
Issue
12
Start / End Page
E158 / E158
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Schumacher-Bass, S. M., Gao, E., Chuprun, K., Tesmer, J. J., & Koch, W. J. (2013). Paroxetine-mediated GRK2 Inhibition Improves Cardiovascular Outcomes Post Myocardial Infarction. In CIRCULATION RESEARCH (Vol. 113, pp. E158–E158).
Schumacher-Bass, Sarah M., Erhe Gao, Kurt Chuprun, John J. Tesmer, and Walter J. Koch. “Paroxetine-mediated GRK2 Inhibition Improves Cardiovascular Outcomes Post Myocardial Infarction.” In CIRCULATION RESEARCH, 113:E158–E158, 2013.
Schumacher-Bass SM, Gao E, Chuprun K, Tesmer JJ, Koch WJ. Paroxetine-mediated GRK2 Inhibition Improves Cardiovascular Outcomes Post Myocardial Infarction. In: CIRCULATION RESEARCH. 2013. p. E158–E158.
Schumacher-Bass, Sarah M., et al. “Paroxetine-mediated GRK2 Inhibition Improves Cardiovascular Outcomes Post Myocardial Infarction.” CIRCULATION RESEARCH, vol. 113, no. 12, 2013, pp. E158–E158.
Schumacher-Bass SM, Gao E, Chuprun K, Tesmer JJ, Koch WJ. Paroxetine-mediated GRK2 Inhibition Improves Cardiovascular Outcomes Post Myocardial Infarction. CIRCULATION RESEARCH. 2013. p. E158–E158.
Published In
CIRCULATION RESEARCH
EISSN
1524-4571
ISSN
0009-7330
Publication Date
2013
Volume
113
Issue
12
Start / End Page
E158 / E158
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology